Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Homologous Recombination Inquiry Through Ovarian Malignancy Investigations

NCT03159572 is registered in ClinicalTrials.gov with Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan as lead sponsor.

NCT NCT03159572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
Lead sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase
Observational
Overall status
Completed
Start date
March 28, 2017
Completion date
February 16, 2022
Enrollment
996 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer, primary peritoneal cancer